Identification of a Neuronal Cdk5 Activator-binding Protein as Cdk5 Inhibitor
Open accessThe DOI matches its Crossref record.
Abstract
Neuronal Cdc2-like kinase (Nclk) plays an important role in a variety of cellular processes, including neuronal cell differentiation, apoptosis, neuron migration, and formation of neuromuscular junction. The active kinase consists of a catalytic subunit, Cdk5, and an essential regulatory subunit, neuronal Cdk5 activator (p35(nck5a) or p25(nck5a)), which is expressed primarily in neurons of central nervous tissue. In our previous study using the yeast two-hybrid screening method, three novel p35(nck5a)-associated proteins were isolated. Here we show that one of these proteins, called C42, specifically inhibits the activation of Cdk5 by Nck5a. Co-immunoprecipitation data suggested that C42 and p35(nck5a) could form a complex within cultured mammalian cells. Deletion analysis has mapped the inhibitory domain of C42 to a region of 135 amino acids, which is conserved in Pho81, a yeast protein that inhibits the yeast cyclin-dependent protein kinase Pho85. The Pho85.Pho80 kinase complex has been shown to be the yeast functional homologue of the mammalian Cdk5/p35(nck5a) kinase.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L., Erdos, M. R., Stringham, H. M., Chines, P. S., Jackson, A. U., et al. (2007) · Science · doi:10.1126/science.1142382 · Cited by 2,753
A variant in CDKAL1 influences insulin response and risk of type 2 diabetes
Steinthorsdottir, V., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Jonsdottir, T., Walters, G. B., Styrkarsdottir, U., Gretarsdottir, S., Emilsson, V., Ghosh, S., et al. (2007) · Nature Genetics · doi:10.1038/ng2043 · Cited by 1,072
“CDK5RAP1 is expressed in neuronal tissues, where it inhibits cyclin-dependent kinase 5 (CDK5) activity by binding to the CDK5 regulatory subunit p35 (ref”
BackgroundIdentification of piRNAs in the central nervous system
Lee, E. J., Banerjee, S., Zhou, H., Jammalamadaka, A., Arcila, M., Manjunath, B. S., & Kosik, K. S. (2011) · RNA · doi:10.1261/rna.2565011 · Cited by 289
A Genome-Wide Association Study of Gestational Diabetes Mellitus in Korean Women
Kwak, S. H., Kim, S.-H., Cho, Y. M., Go, M. J., Cho, Y. S., Choi, S. H., Moon, M. K., Jung, H. S., Shin, H. D., Kang, H. M., et al. (2012) · Diabetes · doi:10.2337/db11-1034 · Cited by 276
A novel CDK5‐dependent pathway for regulating GSK3 activity and kinesin‐driven motility in neurons
Morfini, G., Szebenyi, G., Brown, H., Pant, H. C., Pigino, G., DeBoer, S., Beffert, U., & Brady, S. T. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600237 · Cited by 268
Metadata
- Authors
- Ching, Y.-P., Pang, A. S. H., Lam, W.-H., Qi, R. Z., & Wang, J. H.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-05
- Volume
- 277
- Issue
- 18
- Pages
- 15237-15240
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2018262559
- Cited by
- 77
- References
- 0
- FWCI
- 1.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Identification of a Neuronal Cdk5 Activator-binding Protein as Cdk5 Inhibitor. https://app.cochat.ai/papers/10.1074/jbc.c200032200
- The paper
- Ching, Y.-P., Pang, A. S. H., Lam, W.-H., Qi, R. Z., & Wang, J. H. (2002). Identification of a Neuronal Cdk5 Activator-binding Protein as Cdk5 Inhibitor. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.c200032200
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.